RAFプロトオンコジーンセリン/スレオニンプロテインキナーゼの世界市場2020年：メーカー別、地域別、種類・用途別

• 英文タイトル：Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：MRC2012A7810 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、RAFプロトオンコジーンセリン/スレオニンプロテインキナーゼの世界市場を広く調査・分析し、今後の市場展望をまとめております。RAFプロトオンコジーンセリン/スレオニンプロテインキナーゼの種類別市場規模（LXH-254、HM-95573、DCBCI-0902、BAL-3833、その他）、用途別市場規模（固形腫瘍、結腸直腸癌、肝臓癌、肺腺癌、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Basilea Pharmaceutica AG、Sirnaomics, Inc.、Hanmi Pharmaceuticals, Co. Ltd.、Eli Lilly and Company、Redx Pharma Plc、F. Hoffmann-La Roche Ltd.、Novartis AG、Millennium Pharmaceuticals, Inc.、VG Life Sciences, Inc.、 ・地域別グローバル市場分析 2015年-2020年 ・RAFプロトオンコジーンセリン/スレオニンプロテインキナーゼの北米市場（アメリカ、カナダ、メキシコ） ・RAFプロトオンコジーンセリン/スレオニンプロテインキナーゼのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・RAFプロトオンコジーンセリン/スレオニンプロテインキナーゼのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・RAFプロトオンコジーンセリン/スレオニンプロテインキナーゼの南米市場（ブラジル、アルゼンチン） ・RAFプロトオンコジーンセリン/スレオニンプロテインキナーゼの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：LXH-254、HM-95573、DCBCI-0902、BAL-3833、その他 ・用途別分析：固形腫瘍、結腸直腸癌、肝臓癌、肺腺癌、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global RAF Proto Oncogene Serine/Threonine Protein Kinase market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The RAF Proto Oncogene Serine/Threonine Protein Kinase market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
RAF Proto Oncogene Serine/Threonine Protein Kinase market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, RAF Proto Oncogene Serine/Threonine Protein Kinase market has been segmented into
LXH-254
HM-95573
DCBCI-0902
BAL-3833
Others

By Application, RAF Proto Oncogene Serine/Threonine Protein Kinase has been segmented into:
Solid Tumor
Colorectal Cancer
Liver Cancer
Lung Adenocarcinoma
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global RAF Proto Oncogene Serine/Threonine Protein Kinase market presented in the report. This section sheds light on the sales growth of different regional and country-level RAF Proto Oncogene Serine/Threonine Protein Kinase markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global RAF Proto Oncogene Serine/Threonine Protein Kinase market.

The report offers in-depth assessment of the growth and other aspects of the RAF Proto Oncogene Serine/Threonine Protein Kinase market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and RAF Proto Oncogene Serine/Threonine Protein Kinase Market Share Analysis
RAF Proto Oncogene Serine/Threonine Protein Kinase competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, RAF Proto Oncogene Serine/Threonine Protein Kinase sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the RAF Proto Oncogene Serine/Threonine Protein Kinase sales, revenue and market share for each player covered in this report.

The major players covered in RAF Proto Oncogene Serine/Threonine Protein Kinase are:
Basilea Pharmaceutica AG
Sirnaomics, Inc.
Hanmi Pharmaceuticals, Co. Ltd.
Eli Lilly and Company
Redx Pharma Plc
F. Hoffmann-La Roche Ltd.
Novartis AG
Millennium Pharmaceuticals, Inc.
VG Life Sciences, Inc.

Among other players domestic and global, RAF Proto Oncogene Serine/Threonine Protein Kinase market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe RAF Proto Oncogene Serine/Threonine Protein Kinase product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of RAF Proto Oncogene Serine/Threonine Protein Kinase, with price, sales, revenue and global market share of RAF Proto Oncogene Serine/Threonine Protein Kinase in 2018 and 2019.
Chapter 3, the RAF Proto Oncogene Serine/Threonine Protein Kinase competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the RAF Proto Oncogene Serine/Threonine Protein Kinase breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, RAF Proto Oncogene Serine/Threonine Protein Kinase market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe RAF Proto Oncogene Serine/Threonine Protein Kinase sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 RAF Proto Oncogene Serine/Threonine Protein Kinase Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 LXH-254
1.2.3 HM-95573
1.2.4 DCBCI-0902
1.2.5 BAL-3833
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Solid Tumor
1.3.3 Colorectal Cancer
1.3.4 Liver Cancer
1.3.5 Lung Adenocarcinoma
1.3.6 Others
1.4 Overview of Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market
1.4.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Basilea Pharmaceutica AG
2.1.1 Basilea Pharmaceutica AG Details
2.1.2 Basilea Pharmaceutica AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Basilea Pharmaceutica AG SWOT Analysis
2.1.4 Basilea Pharmaceutica AG Product and Services
2.1.5 Basilea Pharmaceutica AG RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sirnaomics, Inc.
2.2.1 Sirnaomics, Inc. Details
2.2.2 Sirnaomics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sirnaomics, Inc. SWOT Analysis
2.2.4 Sirnaomics, Inc. Product and Services
2.2.5 Sirnaomics, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Hanmi Pharmaceuticals, Co. Ltd.
2.3.1 Hanmi Pharmaceuticals, Co. Ltd. Details
2.3.2 Hanmi Pharmaceuticals, Co. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Hanmi Pharmaceuticals, Co. Ltd. SWOT Analysis
2.3.4 Hanmi Pharmaceuticals, Co. Ltd. Product and Services
2.3.5 Hanmi Pharmaceuticals, Co. Ltd. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eli Lilly and Company SWOT Analysis
2.4.4 Eli Lilly and Company Product and Services
2.4.5 Eli Lilly and Company RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Redx Pharma Plc
2.5.1 Redx Pharma Plc Details
2.5.2 Redx Pharma Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Redx Pharma Plc SWOT Analysis
2.5.4 Redx Pharma Plc Product and Services
2.5.5 Redx Pharma Plc RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 F. Hoffmann-La Roche Ltd.
2.6.1 F. Hoffmann-La Roche Ltd. Details
2.6.2 F. Hoffmann-La Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.6.4 F. Hoffmann-La Roche Ltd. Product and Services
2.6.5 F. Hoffmann-La Roche Ltd. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis AG
2.7.1 Novartis AG Details
2.7.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis AG SWOT Analysis
2.7.4 Novartis AG Product and Services
2.7.5 Novartis AG RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Millennium Pharmaceuticals, Inc.
2.8.1 Millennium Pharmaceuticals, Inc. Details
2.8.2 Millennium Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Millennium Pharmaceuticals, Inc. SWOT Analysis
2.8.4 Millennium Pharmaceuticals, Inc. Product and Services
2.8.5 Millennium Pharmaceuticals, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 VG Life Sciences, Inc.
2.9.1 VG Life Sciences, Inc. Details
2.9.2 VG Life Sciences, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 VG Life Sciences, Inc. SWOT Analysis
2.9.4 VG Life Sciences, Inc. Product and Services
2.9.5 VG Life Sciences, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Market Share by Manufacturer (2018-2019)
3.2 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 RAF Proto Oncogene Serine/Threonine Protein Kinase Manufacturer Market Share in 2019
3.3.2 Top 6 RAF Proto Oncogene Serine/Threonine Protein Kinase Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Market Share by Regions
4.1.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Market Share by Regions (2015-2020)
4.1.2 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue and Market Share by Regions (2015-2020)
4.2 North America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
4.3 Europe RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
4.5 South America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Market Share by Country
5.1.1 North America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Market Share by Country (2015-2020)
5.1.2 North America RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue and Market Share by Country (2015-2020)
5.2 United States RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
5.3 Canada RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
5.4 Mexico RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Market Share by Country
6.1.1 Europe RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Market Share by Country (2015-2020)
6.1.2 Europe RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue and Market Share by Country (2015-2020)
6.2 Germany RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
6.3 UK RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
6.4 France RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
6.5 Russia RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
6.6 Italy RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue and Market Share by Regions (2015-2020)
7.2 China RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
7.3 Japan RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
7.4 Korea RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
7.5 India RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
7.6 Southeast Asia RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
7.7 Australia RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Market Share by Country
8.1.1 South America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Market Share by Country (2015-2020)
8.1.2 South America RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue and Market Share by Country (2015-2020)
8.2 Brazil RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
8.3 Argentina RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
9.3 Turkey RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
9.4 Egypt RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
9.5 South Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Market Share by Type (2015-2020)
10.2 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue and Market Share by Type (2015-2020)
10.3 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Price by Type (2015-2020)
11 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market Segment by Application
11.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Market Share by Application (2015-2020)
11.2 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Market Share by Application (2015-2020)
11.3 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Price by Application (2015-2020)
12 Market Forecast
12.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Growth Rate (2021-2025)
12.2 RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast by Regions (2021-2025)
12.2.1 North America RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast (2021-2025)
12.2.2 Europe RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast (2021-2025)
12.2.3 Asia-Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast (2021-2025)
12.2.4 South America RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast (2021-2025)
12.2.5 Middle East & Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast (2021-2025)
12.3 RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast by Type (2021-2025)
12.3.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Forecast by Type (2021-2025)
12.3.2 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market Share Forecast by Type (2021-2025)
12.4 RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast by Application (2021-2025)
12.4.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Forecast by Application (2021-2025)
12.4.2 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of RAF Proto Oncogene Serine/Threonine Protein Kinase by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Basilea Pharmaceutica AG Basic Information, Manufacturing Base and Competitors
Table 8. Basilea Pharmaceutica AG RAF Proto Oncogene Serine/Threonine Protein Kinase Major Business
Table 9. Basilea Pharmaceutica AG RAF Proto Oncogene Serine/Threonine Protein Kinase Total Revenue (USD Million) (2017-2018)
Table 10. Basilea Pharmaceutica AG SWOT Analysis
Table 11. Basilea Pharmaceutica AG RAF Proto Oncogene Serine/Threonine Protein Kinase Product and Services
Table 12. Basilea Pharmaceutica AG RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sirnaomics, Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Sirnaomics, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Major Business
Table 15. Sirnaomics, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Total Revenue (USD Million) (2017-2018)
Table 16. Sirnaomics, Inc. SWOT Analysis
Table 17. Sirnaomics, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Product and Services
Table 18. Sirnaomics, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Hanmi Pharmaceuticals, Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table 20. Hanmi Pharmaceuticals, Co. Ltd. RAF Proto Oncogene Serine/Threonine Protein Kinase Major Business
Table 21. Hanmi Pharmaceuticals, Co. Ltd. RAF Proto Oncogene Serine/Threonine Protein Kinase Total Revenue (USD Million) (2017-2018)
Table 22. Hanmi Pharmaceuticals, Co. Ltd. SWOT Analysis
Table 23. Hanmi Pharmaceuticals, Co. Ltd. RAF Proto Oncogene Serine/Threonine Protein Kinase Product and Services
Table 24. Hanmi Pharmaceuticals, Co. Ltd. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 26. Eli Lilly and Company RAF Proto Oncogene Serine/Threonine Protein Kinase Major Business
Table 27. Eli Lilly and Company RAF Proto Oncogene Serine/Threonine Protein Kinase Total Revenue (USD Million) (2017-2018)
Table 28. Eli Lilly and Company SWOT Analysis
Table 29. Eli Lilly and Company RAF Proto Oncogene Serine/Threonine Protein Kinase Product and Services
Table 30. Eli Lilly and Company RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Redx Pharma Plc Basic Information, Manufacturing Base and Competitors
Table 32. Redx Pharma Plc RAF Proto Oncogene Serine/Threonine Protein Kinase Major Business
Table 33. Redx Pharma Plc RAF Proto Oncogene Serine/Threonine Protein Kinase Total Revenue (USD Million) (2017-2018)
Table 34. Redx Pharma Plc SWOT Analysis
Table 35. Redx Pharma Plc RAF Proto Oncogene Serine/Threonine Protein Kinase Product and Services
Table 36. Redx Pharma Plc RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 38. F. Hoffmann-La Roche Ltd. RAF Proto Oncogene Serine/Threonine Protein Kinase Major Business
Table 39. F. Hoffmann-La Roche Ltd. RAF Proto Oncogene Serine/Threonine Protein Kinase Total Revenue (USD Million) (2017-2018)
Table 40. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 41. F. Hoffmann-La Roche Ltd. RAF Proto Oncogene Serine/Threonine Protein Kinase Product and Services
Table 42. F. Hoffmann-La Roche Ltd. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 44. Novartis AG RAF Proto Oncogene Serine/Threonine Protein Kinase Major Business
Table 45. Novartis AG RAF Proto Oncogene Serine/Threonine Protein Kinase Total Revenue (USD Million) (2017-2018)
Table 46. Novartis AG SWOT Analysis
Table 47. Novartis AG RAF Proto Oncogene Serine/Threonine Protein Kinase Product and Services
Table 48. Novartis AG RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Millennium Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 50. Millennium Pharmaceuticals, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Major Business
Table 51. Millennium Pharmaceuticals, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Total Revenue (USD Million) (2017-2018)
Table 52. Millennium Pharmaceuticals, Inc. SWOT Analysis
Table 53. Millennium Pharmaceuticals, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Product and Services
Table 54. Millennium Pharmaceuticals, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. VG Life Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 56. VG Life Sciences, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Major Business
Table 57. VG Life Sciences, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Total Revenue (USD Million) (2017-2018)
Table 58. VG Life Sciences, Inc. SWOT Analysis
Table 59. VG Life Sciences, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Product and Services
Table 60. VG Life Sciences, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Manufacturer (2018-2019) (K Pcs)
Table 62. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Regions (2015-2020) (K Pcs)
Table 64. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Market Share by Regions (2015-2020)
Table 65. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Regions (2015-2020) (USD Million)
Table 66. North America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Countries (2015-2020) (K Pcs)
Table 67. North America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Market Share by Countries (2015-2020)
Table 68. North America RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Countries (2015-2020) (USD Million)
Table 69. North America RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Market Share by Countries (2015-2020)
Table 70. Europe RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Countries (2015-2020) (K Pcs)
Table 71. Europe RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Market Share by Countries (2015-2020)
Table 72. Europe RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Regions (2015-2020) (K Pcs)
Table 74. Asia-Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Regions (2015-2020) (USD Million)
Table 76. South America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Countries (2015-2020) (K Pcs)
Table 77. South America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Market Share by Countries (2015-2020)
Table 78. South America RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Countries (2015-2020) (USD Million)
Table 79. South America RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Countries (2015-2020) (K Pcs)
Table 81. Middle East & Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Market Share by Countries (2015-2020)
Table 84. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Type (2015-2020) (K Pcs)
Table 85. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Share by Type (2015-2020)
Table 86. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Type (2015-2020) (USD Million)
Table 87. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Share by Type (2015-2020)
Table 88. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Application (2015-2020) (K Pcs)
Table 89. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Share by Application (2015-2020)
Table 90. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Forecast by Regions (2021-2025) (K Pcs)
Table 91. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market Share Forecast by Regions (2021-2025)
Table 92. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Forecast by Type (2021-2025) (K Pcs)
Table 93. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market Share Forecast by Type (2021-2025)
Table 94. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Forecast by Application (2021-2025)
Table 95. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. RAF Proto Oncogene Serine/Threonine Protein Kinase Picture
Figure 2. Global Sales Market Share of RAF Proto Oncogene Serine/Threonine Protein Kinase by Type in 2019
Figure 3. LXH-254 Picture
Figure 4. HM-95573 Picture
Figure 5. DCBCI-0902 Picture
Figure 6. BAL-3833 Picture
Figure 7. Others Picture
Figure 8. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Market Share by Application in 2018
Figure 9. Solid Tumor Picture
Figure 10. Colorectal Cancer Picture
Figure 11. Liver Cancer Picture
Figure 12. Lung Adenocarcinoma Picture
Figure 13. Others Picture
Figure 14. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Market Share by Manufacturer in 2019
Figure 35. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 RAF Proto Oncogene Serine/Threonine Protein Kinase Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 RAF Proto Oncogene Serine/Threonine Protein Kinase Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Market Share by Regions (2015-2020)
Figure 42. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Market Share by Regions in 2018
Figure 43. North America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
Figure 44. Europe RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
Figure 46. South America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020)
Figure 48. North America RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Market Share by Countries (2015-2020)
Figure 50. North America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Market Share by Countries in 2018
Figure 51. North America RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Market Share by Countries in 2018
Figure 53. United States RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Market Share by Countries (2015-2020)
Figure 58. Europe RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Market Share by Countries in 2019
Figure 59. Germany RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Market Share by Regions 2019
Figure 66. Asia-Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Market Share by Regions 2019
Figure 67. China RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Market Share by Countries in 2019
Figure 74. South America RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Market Share by Countries in 2019
Figure 75. Brazil RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel

---